Mental health has moved from the margins to the center of the global healthcare conversation. Rising anxiety, depression, and ...

A small company can now advance its psychedelic into phase 3. Here’s why that matters to other psychedelic biotechs. A small ...

Though psychedelic therapies and related psychedelic stocks have fallen out of favor recently, there’s still tremendous research and insight happening beneath the surface. Even Elon Musk uses ketamine ...

CMPS has benefited from positive phase 3 trial results and positive political developments since my last article. Click here ...

Jason Najum covers the psychedelic space and contextualizes recent news around the FDA, MDMA, PTSD, and Lykos Therapeutics. Why it may be a blessing in disguise for Cybin, COMPASS Pathways, and ...

In this article, we will be taking a look at the 13 Best Psychedelic Stocks to Invest in Now. Unlike drugs such as cocaine or marijuana, psychedelics create an “alternate reality” by altering feelings ...

A panel of advisors to the Food and Drug Administration (FDA) rejected MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday, citing a lack of evidence that the benefits would ...